BioSpace News Archive

The U.S. Department of Defense awarded Moderna a contract worth $1,966,598,000 for an additional 100 million doses of its COVID-19 vaccine.

Presidio Bay Ventures partnered with Kinship Capital to acquire a piece of property in the Northern California city to redevelop into a space for the life sciences industry.

rBIO launched last week with technology that can reduce the cost of insulin by 30 percent, making U.S. manufacturing cost-effective for insulin and several other drugs.

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

Alzamend Neuro®, Inc. (“Alzamend” or the “Company”) today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”).

Cybin Inc., a life sciences company focused on psychedelic pharmaceutical therapies, announces the unaudited financial results of Clarmin Explorations Inc. for the three month period ended October 31, 2020.

Celltrion submitted today an application for Conditional Marketing Authorisation of CT-P59, an anti-COVID-19 monoclonal antibody treatment candidate to the Korean Ministry of Food and Drug Safety (MFDS) Celltrion plans to submit Emergency Use Authorisation (EUA) to the U.S. FDA and Conditional Marketing Authorisation (CMA) to theEuropean Medicines Agency (EMA) for CT-P59 in the coming months

The growing clinical acceptance of drug-free alternatives to painkiller pharmaceuticals among the general population is a key driver for the evolution in the pain management devices market.

Ophthalmic refractometer is an equipment which is used for measuring lens strength and power, in order to provide patients with proper eyeglasses for correcting their vision.

The global medical equipment maintenance market is expected to grow at promising pace during the assessment period 2019–2029.